Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts

Figure 1

Kaplan–Meier analysis of graft survival censored for death within the first year after transplantation (a) of recipients with or without pretransplantation of donor-specific anti-HLA antibodies (DSA). (b, c) show the cumulative hazard of antibody-mediated rejection (ABMR) and T cell-mediated rejection (TCMR) for recipients within the first year after transplantation according to their status of pretransplant DSA (present or absent). values are obtained by the log rank test statistics pairwise over strata.

(a)

(b)

(c)